The deal sparked some early confusion over the price tag. Initial coverage from Crain's Chicago Business reported an $82.5 ...
It was an eventful week for Mylan N.V. (NASDAQ: MYL). The generic drugmaker received good news from an Israeli court related to its attempt to take over Perrigo (NYSE: PRGO). It launched a new drug in ...
On June 16, 2020, Mylan N.V. (the "Company" or "Mylan") and Mylan Inc. (the "Borrower") entered into Amendment No. 2 (the "Revolving Amendment") to the Revolving Credit Agreement dated as of July 27, ...
NEW YORK--(BUSINESS WIRE)--Nussbaum Law Group, P.C. and Roberts Law Firm US, PC: A proposed settlement (“Settlement”) has been reached in a class action lawsuit alleging that Mylan N.V., Mylan ...
What: Shares of the specialty and generic drugmaker Mylan fell by more than 14% today on heavy volume after Teva Pharmaceutical Industries Ltd. dropped its $40 billion hostile takeover bid. Instead, ...
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good. However, our research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results